Dentsply Sirona (NASDAQ: XRAY) appoints Donald Zurbay to board of directors

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. reported that its Board of Directors, following a recommendation from the Corporate Governance and Nominating Committee, increased the size of the Board from 10 to 11 members, effective January 10, 2026.

On the same date, the Board appointed Donald J. Zurbay as a director, with his term running until the election of directors at the 2026 annual meeting of stockholders. He will also serve on the Board’s Audit and Finance Committee. The company notes that he has no family relationships with existing leaders and no material related-party transactions requiring disclosure. He will receive the same compensation as other non-employee directors. The company furnished, but did not file, a press release about his appointment as Exhibit 99.1.

0000818479false00008184792026-01-102026-01-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

January 10, 2026

Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of principal executive offices)

(Zip Code)

(844) 848-0137

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 10, 2026, upon the recommendation of the Corporate Governance and Nominating Committee (the “Governance Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”), and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 10 to 11, effective immediately.

Upon the further recommendation of the Governance Committee, the Board appointed Mr. Donald J. Zurbay to the Board, effective immediately. Mr. Zurbay will hold such office until the election of directors at the 2026 annual meeting of stockholders. Mr. Zurbay will serve as a member of the Audit and Finance Committee of the Board.

Mr. Zurbay does not have any family relationship with any director or executive officer of the Company, or any person nominated or chosen by the Company to become a director or executive officer, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Mr. Zurbay will participate in the same compensation plans as the other non-employee members of the Board, as described under “Directors’ Compensation” in the Company’s definitive proxy statement filed with the SEC on April 9, 2025 for the Company’s 2025 annual meeting of stockholders.

Item 7.01 Regulation FD Disclosure

The Company’s press release announcing the appointment of Mr. Zurbay as a member of the Board is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.						Description
99.1						DENTSPLY SIRONA Inc. Press Release Issued January 13, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                         DENTSPLY SIRONA Inc.

By:						/s/ Daniel T. Scavilla
Name:						Daniel T. Scavilla
Title:						President and Chief Executive Officer

Date: January 13, 2026

FAQ

What did DENTSPLY SIRONA (XRAY) announce in this 8-K filing?

The company disclosed that its Board of Directors increased its size from 10 to 11 members and appointed Donald J. Zurbay as a new director, effective January 10, 2026.

Who is the new director appointed to DENTSPLY SIRONA's board?

DENTSPLY SIRONA appointed Donald J. Zurbay to its Board of Directors. He will serve until the election of directors at the 2026 annual meeting of stockholders and will sit on the Audit and Finance Committee.

How did DENTSPLY SIRONA change the size of its Board of Directors?

Upon recommendation of the Corporate Governance and Nominating Committee, the Board approved an increase in the number of directors from 10 to 11, effective immediately on January 10, 2026.

Does Donald J. Zurbay have related-party ties to DENTSPLY SIRONA?

The company states that Mr. Zurbay has no family relationship with any director or executive officer and no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.

What compensation will Donald J. Zurbay receive as a DENTSPLY SIRONA director?

Mr. Zurbay will participate in the same compensation plans as other non-employee members of the Board, as described in the company’s definitive proxy statement for its 2025 annual meeting of stockholders.

How did DENTSPLY SIRONA communicate the board appointment to the market?

The company issued a press release announcing Mr. Zurbay’s appointment, which is furnished (not filed) as Exhibit 99.1 to this report and is not automatically incorporated into other SEC filings.